HEPATOCELLULAR CARCINOMA NON-RESECTABLE
Clinical trials for HEPATOCELLULAR CARCINOMA NON-RESECTABLE explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CARCINOMA NON-RESECTABLE trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CARCINOMA NON-RESECTABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to shrink untreatable liver tumors
Disease control OngoingThis phase II trial tests whether combining two immunotherapy drugs (durvalumab and tremelimumab) with a radiation procedure called Y-90 SIRT can shrink liver tumors in people with intermediate-stage liver cancer that cannot be removed by surgery. About 55 participants will recei…
Matched conditions: HEPATOCELLULAR CARCINOMA NON-RESECTABLE
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New combo shrinks untouchable liver tumors, opens door to surgery
Disease control OngoingThis phase 2 trial tests whether a powerful mix of liver-directed chemotherapy, a targeted drug (lenvatinib), and an immunotherapy (cadonilimab) can shrink liver cancers that were too large or widespread to remove. The goal is to convert these inoperable tumors into ones that can…
Matched conditions: HEPATOCELLULAR CARCINOMA NON-RESECTABLE
Phase: PHASE2 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Radioactive lipiodol takes aim at inoperable liver tumors
Disease control TerminatedThis phase II trial tests a targeted radiation therapy called 188Re-SSS lipiodol for people with liver cancer that cannot be surgically removed. The treatment delivers radiation directly to the tumor through the liver's blood vessels. The study aims to see how many patients' tumo…
Matched conditions: HEPATOCELLULAR CARCINOMA NON-RESECTABLE
Phase: PHASE2 • Sponsor: Center Eugene Marquis • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Radioactive beads take aim at untreatable liver tumors
Disease control OngoingThis study is testing a treatment called Eye90 microspheres for people with liver cancer that cannot be removed by surgery. The microspheres are tiny glass beads containing radioactive yttrium-90, which are injected into the liver's blood vessels to deliver radiation directly to …
Matched conditions: HEPATOCELLULAR CARCINOMA NON-RESECTABLE
Phase: NA • Sponsor: ABK Biomedical • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC